Cargando…
Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
The clinical use of doxorubicin in cancer is limited by cardiotoxic effects that can lead to heart failure. Whereas earlier work focused on the direct impact of doxorubicin on cardiomyocytes, recent studies have turned to the endothelium, because doxorubicin-damaged endothelial cells can trigger the...
Autores principales: | Luu, Albert Z., Chowdhury, Biswajit, Al-Omran, Mohammed, Teoh, Hwee, Hess, David A., Verma, Subodh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314956/ https://www.ncbi.nlm.nih.gov/pubmed/30623145 http://dx.doi.org/10.1016/j.jacbts.2018.06.005 |
Ejemplares similares
-
Loss of endothelial cell-specific autophagy-related protein 7 exacerbates doxorubicin-induced cardiotoxicity
por: Luu, Albert Z., et al.
Publicado: (2021) -
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review
por: Lopaschuk, Gary D., et al.
Publicado: (2020) -
Pathogenic Mechanisms of Pulmonary Arterial Hypertension: Homeostasis Imbalance of Endothelium-Derived Relaxing and Contracting Factors
por: Zhu, Jinsheng, et al.
Publicado: (2022) -
New insights into the activities and toxicities of the old anticancer drug doxorubicin
por: van der Zanden, Sabina Y., et al.
Publicado: (2020) -
Restrictive cardiomyopathy: definition and diagnosis
por: Rapezzi, Claudio, et al.
Publicado: (2022)